Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Propanc Biopharma Inc (PPCB) had Return on Equity of -29.28% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-4.07M |
|
-- |
|
-- |
|
$3.66M |
|
$-3.66M |
|
$-0.43M |
|
$-4.07M |
|
$-4.07M |
|
$-4.07M |
|
$-4.07M |
|
$-4.07M |
|
$-4.07M |
|
$-3.66M |
|
$-3.66M |
|
3.97M |
|
3.97M |
|
$29.88 |
|
$29.88 |
|
| Balance Sheet Financials | |
$8.35M |
|
-- |
|
$11.28M |
|
$19.63M |
|
$5.58M |
|
$0.11M |
|
$0.15M |
|
$5.73M |
|
$13.91M |
|
$13.91M |
|
$13.91M |
|
11.61M |
|
| Cash Flow Statement Financials | |
$-0.41M |
|
-- |
|
$0.49M |
|
$0.02M |
|
$0.01M |
|
$-0.01M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.50 |
|
-- |
|
-- |
|
0.01 |
|
0.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-29.28% |
-29.28% |
|
-20.74% |
|
-29.06% |
|
$1.20 |
|
$-0.10 |
|
$-0.10 |
|